The U.S. Food and Drug Administration (FDA) has officially approved Novartis’ latest gene replacement therapy, Itvisma, marking a significant milestone in the treatment landscape ...
Treatment of type 1 diabetes (T1D) is entering a transformative era. The first immunotherapy approved to delay clinical onset—Teplizumab—has received FDA approval in the United S...
Many patients believe brand-name drugs are always safer than generics. But that’s a misunderstanding.Drug safety depends on regulation, not branding.What’s the Difference?An orig...